GlassScriptPhysician profile
Augustus Cullen Richardson
NPI 1659368371
$3,253.67
in general payments reported to CMS, 2019-2025
27 companies · $451 in 2025
The $451 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $1,510 · 2021: $286 · 2022: $299 · 2023: $222 · 2024: $342 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,015.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Senseonics, Incorporated | $1,454.00 | 2019-2020 | |
| Organogenesis INC. | $403.34 | 2021-2025 | Cygnus Dual, Puraply, Via Matrix |
| Regeneron Healthcare Solutions, INC. | $371.49 | 2023-2025 | Libtayo |
| Medtronic, INC. | $315.44 | 2022-2025 | Maxtack, Gi Genius, Venaseal |
| Smith+Nephew, INC. | $98.13 | 2023-2025 | Collagenase Santyl, Iodosorb Ointment 40g USA, Regranex |
| Trevena, INC. | $79.70 | 2022-2023 | Olinvyk |
| Ferring Pharmaceuticals INC. | $58.49 | 2019 | |
| Apollo Endosurgery US INC | $55.56 | 2019 | |
| Kerecis Limited | $44.14 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Mauna Kea Technologies, INC. | $37.22 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $36.86 | 2021-2024 | Exparel |
| Kci USA, INC. | $31.07 | 2021 | |
| Boston Scientific Corporation | $28.55 | 2020-2023 | Varithena Administration Pack |
| Braintree Laboratories, INC. | $25.06 | 2021 | |
| W. L. Gore & Associates, INC. | $24.78 | 2020-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $24.46 | 2020 | |
| Merck Sharp & Dohme LLC | $21.41 | 2020 | |
| Innocoll Pharmaceuticals Limited | $19.14 | 2022 | |
| Angiodynamics, INC. | $18.42 | 2021 | |
| Vioptix INC | $16.49 | 2022 | |
| Ethicon US, LLC | $16.01 | 2024 | Surgicel Nu-Knit, Echelon Circular, Linx Reflux Management System |
| Dilon Technologies, INC. | $16.00 | 2024 | Hemoblast Bellows |
| Mimedx Group, INC. | $15.32 | 2024 | |
| Portola Pharmaceuticals, LLC | $15.15 | 2019 | |
| Davol INC. | $13.91 | 2021 | |
| Phathom Pharmaceuticals, INC. | $8.60 | 2025 | Voquezna |
| Thd America, INC. | $4.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Augustus Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.